Novartis AG is partnering with a Canadian cannabis company backed by billionaire Peter Thiel to get in on the medical marijuana business. The health-care giant’s Sandoz Canada Inc. division is forming a strategic alliance with Tilray, which makes cannabis medicines in capsules and other forms. Read More
The post Novartis Teams Up With Thiel-Backed Canadian Marijuana Startup appeared first on Dagga Magazine.